Techbio is a fascinating field that merges data, technology, and biology to elevate scientific processes. In the latest episode of NVIDIA’s AI Podcast, host Noah Kravitz engages in an insightful conversation with Chris Gibson, the co-founder and CEO of Recursion. They delve into how AI and machine learning are revolutionizing drug discovery and development on a large scale at Recursion. Tune in to discover how AI is reshaping the biopharmaceutical industry by enhancing efficiency and reducing discovery costs.
Time Stamps
0:58: Background on Recursion
6:23: Recursion’s approach to drug discovery
12:06: Empirical data generation and generative AI prediction
17:46: How supercomputing is accelerating drug discovery
22:32: What is techbio?
29:15: The future — using natural language prompts to work with AI systems
31:44: Recursion’s plans for the future
You Might Also Like:
Cardiac Clarity: Dr. Keith Channon Talks Revolutionizing Heart Health With AI – Ep. 212
Caristo Diagnostics has developed an AI-powered solution that detects coronary inflammation in cardiac CT scans. Dr. Keith Channon, co-founder and chief medical officer of the company, sheds light on how Caristo leverages AI to enhance treatment plans and risk predictions through personalized patient readouts.
Cofounder of Annalise.ai Aengus Tran on Using AI as a Spell Check for Health Checks – Ep. 207
Harrison.ai, a clinician-led healthcare AI company, has developed annalise.ai, an AI solution that acts as a “spell checker” for radiologists. This innovation aims to improve the speed and accuracy of radiology image analysis by flagging critical findings and reducing misdiagnoses. Aengus Tran, CEO, and co-founder of Harrison.ai, shares insights on the potential of autonomous AI systems to enhance global healthcare capacity.
Matice Founder Jessica Whited on Harnessing Regenerative Species for Medical Breakthroughs – Ep. 198
Matice Biosciences utilizes AI to study tissue regeneration in super-regenerative animal species like salamanders and planarians. Jessica Whited, a regenerative biologist at Harvard and co-founder of Matice Biosciences, explores how the company aims to leverage regenerative species and AI to develop new treatments that facilitate scar-free healing from injuries in humans.
Bojan Tunguz, Johnny Israeli on How AI and Crowdsourcing Can Advance Vaccine Distribution – Ep. 195
The fusion of artificial intelligence, crowdsourcing, and machine learning is enhancing the thermo-stability of mRNA vaccines, making distribution more accessible globally. Bojan Tunguz, a physicist and senior system software engineer at NVIDIA, along with Johnny Israeli, senior manager of AI and cloud software at NVIDIA, delve into the potential of AI, crowdsourcing, and machine learning in revolutionizing drug discovery methodologies.
Subscribe to the AI Podcast
Listen to the AI Podcast on various platforms such as iTunes, Google Play, Amazon Music, Castbox, DoggCatcher, Overcast, PlayerFM, Pocket Casts, Podbay, PodBean, PodCruncher, PodKicker, Soundcloud, Spotify, Stitcher, and TuneIn.
Help us improve the AI Podcast by taking a few minutes to fill out this listener survey.